Finance

Lists
STAA:NASDAQ
STAAR Surgical Co
$23.14
+0.30%
(+0.070) 1D
$23.14
0.00% (0.00)
After hours
Closed: Aug 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STAA...
Open
$23.04
High
$23.46
Low
$23.04
Mkt. cap
1.16B
Avg. vol.
1.06M
Volume
698.39K
P/E ratio
347.19
52-wk high
$35.87
52-wk low
$15.58
EPS
$0.07
Beta
1.26
Shares outstanding
50.14M
No. of employees
921
Open
$23.04
High
$23.46
Low
$23.04
Mkt. cap
1.16B
Avg. vol.
1.06M
Volume
698.39K
P/E ratio
347.19
52-wk high
$35.87
52-wk low
$15.58
EPS
$0.07
Beta
1.26
Shares outstanding
50.14M
No. of employees
921
News stories
From web sources and news partners
About STAAR Surgical Co
CEO-
Employees921
Founded1982
HeadquartersMonrovia, California, United States
SectorMedical device
Websitestaar.com
Analyst ratings
Based on 8 analysts giving stock ratings to STAA in the past 3 months
Hold
Buy
2
Hold
5
Sell
1
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for STAA in the last 3 months.
Highest
Current $23.14
$40.00 (+72.86%)
Average
$29.67 (+28.22%)
Lowest
$20.00 (-13.57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Stephan
Stifel Nicolaus
Hold
Maintained
$28.00
+21%
08/17/2026
David Saxon
Needham
Hold
Maintained
-
-
08/13/2026
Adam Maeder
Piper Sandler
Hold
Reiterated
$33.00
+42.6%
08/13/2026
John Young CFA
Canaccord Genuity
Buy
Maintained
$32.00
+38.3%
08/13/2026
Simran Kaur
Wells Fargo
Hold
Reiterated
$25.00
+8%
08/13/2026
Unknown Analyst
UBS
Sell
Initiated
$20.00
-13.6%
07/28/2026
Patrick Wood
UBS
Sell
Initiated
$20.00
-13.6%
07/28/2026
Michael Piccolo
Wedbush
Buy
Reiterated
$40.00
+72.9%
07/20/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
07/16/2026
Anthony Petrone
Mizuho Securities
Hold
Maintained
$27.00
+16.7%
05/14/2026
Unknown Analyst
Wedbush
Hold
Maintained
$26.00
+12.4%
04/09/2026
Unknown Analyst
Stephens
Hold
Maintained
$28.00
+21%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
94.73M
57.80M
93.52M
93.54M
Cost of goods sold
16.86M
14.06M
24.66M
23.81M
Cost of revenue
16.86M
14.06M
24.66M
23.81M
Research and development expenses
9.21M
9.24M
9.92M
9.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.16M
45.40M
41.45M
49.60M
Operating expense
53.37M
54.65M
51.38M
59.54M
Total operating expenses
70.23M
68.71M
76.04M
83.35M
Operating income
24.50M
-10.91M
17.48M
10.18M
Other non operating income
291.00K
1.62M
366.00K
313.00K
EBT including unusual items
18.79M
-20.65M
8.22M
11.02M
EBT excluding unusual items
24.74M
-8.75M
17.64M
11.02M
Income tax expense
9.91M
-2.34M
3.01M
2.97M
Effective tax rate
52.72%
11.35%
36.65%
26.90%
Other operating expenses
-
-
-
-
Net income
8.88M
-18.31M
5.21M
8.06M
Net profit margin
9.38%
-31.68%
5.57%
8.61%
Earnings per share
0.47
0.01
0.29
0.25
Interest and investment income
790.00K
1.07M
907.00K
939.00K
Interest expense
-
-
-
-
Net interest expenses
790.00K
1.07M
907.00K
939.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
26.50M
-8.90M
19.59M
12.57M
Gain or loss from assets sale
23.00K
-1.41M
-
1.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps